// company-profile
Lexeo Therapeutics, Inc.
LXEOExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Filings82Insiders28
// api This Lexeo Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, Lexeo Therapeutics, Inc. insiders bought $0 (1 transaction) and sold $24K (2 transactions).
- Most active insider: Townsend Richard Nolan with 2 transactions totaling $330K.
- Largest single sale: $313K by Townsend Richard Nolan on Apr 6, 2026.
- 33% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bearish — sales outpace buys.
Institutional Ownership
Top 13F-HR holders of Lexeo Therapeutics, Inc. as of 2026-03-31
Total reported AUM
$451.7M
QoQ change
-35.5%
Reporting period
2026-03-31
#1
Paradigm Biocapital Advisors LP
CIK 1855655
$35.5M
6.2M shares
#2
Affinity Asset Advisors, LLC
CIK 1773195
$29.0M
5.1M shares
#3
RA CAPITAL MANAGEMENT, L.P.
CIK 1346824
$28.7M
5.0M shares
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 18, 2026 | Townsend Richard Nolan | LXEO | Sale | 3,342 | $5.06 | $17K |
| May 18, 2026 | Otero Jose Manuel | LXEO | Sale | 1,302 | $5.07 | $7K |
| Apr 28, 2026 | Sepp-Lorenzino Laura | LXEO | Award | 50,000 | $0.00 | $0K |
| Apr 6, 2026 | Townsend Richard Nolan | LXEO | Sale10b5 | 55,000 | $5.69 | $313K |
| Mar 13, 2026 | Otero Jose Manuel | LXEO | Award | 5,930 | $2.64 | $16K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.